Article info

Original article
The safety of vedolizumab for ulcerative colitis and Crohn's disease

Authors

  1. Correspondence to Professor Jean-Frédéric Colombel, Division of Gastroenterology, Inflammatory Bowel Disease Center, Icahn School of Medicine, Mount Sinai Hospital, 17 East 102nd Street, 5th Floor, New York, NY 10029, USA; jean-frederic.colombel{at}mssm.edu
View Full Text

Citation

Colombel J, Sands BE, Rutgeerts P, et al
The safety of vedolizumab for ulcerative colitis and Crohn's disease

Publication history

  • Received November 11, 2015
  • Revised January 14, 2016
  • Accepted January 15, 2016
  • First published February 18, 2016.
Online issue publication 
April 07, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.